{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:35:31Z","timestamp":1786653331775,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0253-7613.169571","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T01:15:37Z","timestamp":1447722937000},"page":"616","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic effects as a cause of myotoxic effects of fluoroquinolones"],"prefix":"10.4103","volume":"47","author":[{"given":"Thomas","family":"Metterlein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Roewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Anetseder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.169571-1","first-page":"1027","volume-title":"The newer fluoroquinolones","author":"Bolon","year":"2009","journal-title":"Infect Dis Clin North Am"},{"key":"key-10.4103\/0253-7613.169571-2","first-page":"774","volume-title":"Investigation of fluoroquinolone-induced myalgia using (31) P magnetic resonance spectroscopy and in vitro contracture tests","author":"Guis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0253-7613.169571-3","first-page":"1405","volume-title":"Malignant hyperthermia susceptibility revealed by myalgia and rhabdomyolysis during fluoroquinolone treatment","author":"Guis","year":"2001","journal-title":"J Rheumatol"},{"key":"key-10.4103\/0253-7613.169571-4","first-page":"779","volume-title":"A case of rhabdomyolysis with fatal outcome after a treatment with levofloxacin","author":"Petitjeans","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"key-10.4103\/0253-7613.169571-5","first-page":"146","volume-title":"Acute rhabdomyolysis associated with ofloxacin\/levofloxacin therapy","author":"Hsiao","year":"2005","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/0253-7613.169571-6","first-page":"859","volume-title":"Rhabdomyolysis and unexplained malaise.Role of combination of ciprofibrate and norfloxacin","author":"Blain","year":"1996","journal-title":"Rev Med Interne"},{"key":"key-10.4103\/0253-7613.169571-7","first-page":"283","volume-title":"In vitro study of cytotoxicity of quinolones on rabbit tenocytes","author":"Bernard-Beaubois","year":"1998","journal-title":"Cell Biol Toxicol"},{"key":"key-10.4103\/0253-7613.169571-8","first-page":"1203","volume-title":"31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies","author":"Bendahan","year":"1992","journal-title":"Neurology"},{"key":"key-10.4103\/0253-7613.169571-9","first-page":"328","volume-title":"Malignant hyperthermia.General, clinical and experimental aspects","author":"Steinfath","year":"2002","journal-title":"Anaesthesist"},{"key":"key-10.4103\/0253-7613.169571-10","first-page":"693","volume-title":"Measurement of resting cytosolic Ca 2+ concentrations and Ca 2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca 2+ release channels","author":"Tong","year":"1999","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0253-7613.169571-11","first-page":"1579","volume-title":"Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic test","author":"Anetseder","year":"2002","journal-title":"Lancet"},{"key":"key-10.4103\/0253-7613.169571-12","first-page":"468","volume-title":"The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs","author":"Schuster","year":"2006","journal-title":"Anesth Analg"},{"key":"key-10.4103\/0253-7613.169571-13","first-page":"909","volume-title":"An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: A pilot study","author":"Schuster","year":"2008","journal-title":"Anesth Analg"},{"key":"key-10.4103\/0253-7613.169571-14","first-page":"77","volume-title":"Intramuscular injection of malignant hyperthermia trigger agents induces hypermetabolism in susceptible and nonsusceptible individuals","author":"Metterlein","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"key-10.4103\/0253-7613.169571-15","first-page":"1267","volume-title":"The European Malignant Hyperpyrexia Group","author":"A","year":"1984","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0253-7613.169571-16","first-page":"21584","volume-title":"Fluoride-inhibited calcium ATPase of sarcoplasmic reticulum.Magnesium and fluoride stoichiometry","author":"Coll","year":"1992","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0253-7613.169571-17","first-page":"208","volume-title":"Fluoroquinolones influence the intracellular calcium handling in individuals susceptible to malignant hyperthermia","author":"Metterlein","year":"2011","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0253-7613.169571-18","first-page":"616","volume-title":"Intramuscular injection of sevoflurane detects malignant hyperthermia predisposition in susceptible pigs","author":"Schuster","year":"2007","journal-title":"Anesthesiology"},{"key":"key-10.4103\/0253-7613.169571-19","first-page":"767","volume-title":"In-vivo diagnosis of malignant hyperthermia susceptibility: A microdialysis study","author":"Schuster","year":"2008","journal-title":"Anaesthesist"},{"key":"key-10.4103\/0253-7613.169571-20","first-page":"335","volume-title":"Tissue and serum concentrations of levofloxacin in orthopaedic patients","author":"Von","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0253-7613.169571-21","first-page":"78","volume-title":"Tissue distribution of ciprofloxacin following oral and intravenous administration","author":"Dalhoff","year":"1985","journal-title":"Infection"},{"key":"key-10.4103\/0253-7613.169571-22","first-page":"88","volume-title":"Concentration of ciprofloxacin in human prostatic tissue after oral administration","author":"Dan","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0253-7613.169571-23","first-page":"2521","volume-title":"Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: Penetration of the bronchial mucosa","author":"Fabre","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0253-7613.169571-24","first-page":"1114","volume-title":"Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects","author":"Gotfried","year":"2001","journal-title":"Chest"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:35:25Z","timestamp":1786649725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.169571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"alternative-id":["169571"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.169571","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}